Literature DB >> 3027405

Adenovirus early region 1A modulation of interferon antiviral activity.

K P Anderson, E H Fennie.   

Abstract

Human adenovirus type 5 (Ad5) is a DNA virus which replicates as efficiently in human A549 cells treated with human interferon-alpha 2 (IFN) as in untreated cells. Vesicular stomatitis virus (VSV), on the other hand, is a negative-strand RNA virus which is very sensitive to the effects of IFN treatment in A549 cells. The IFN-mediated inhibition of VSV replication was not observed in cells coinfected with Ad5. Abrogation of IFN-mediated antiviral activity was maximal when Ad5 infection preceded VSV infection by at least 36 h, but did not require adenovirus DNA synthesis for manifestation. Coinfection experiments with VSV and deletion variants of adenovirus demonstrated that neither virus-associated RNA synthesis nor expression of adenovirus early regions E1B, E2A, E3, or E4 are required for abrogation of IFN-mediated inhibition of VSV replication. However, expression of early region E1A was essential, suggesting that E1A products can modulate, either directly or indirectly, IFN activity in adenovirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027405      PMCID: PMC254021          DOI: 10.1128/JVI.61.3.787-795.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Interferon action III. The rate of primary transcription of vesicular stomatitis virus is inhibited by interferon action.

Authors:  P I Marcus; M J Sekellick
Journal:  J Gen Virol       Date:  1978-03       Impact factor: 3.891

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. I. Rescue in cell cultures from different species.

Authors:  H R Thacore; J S Youngner
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

4.  Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication.

Authors:  H Persson; U Pettersson; M B Mathews
Journal:  Virology       Date:  1978-10-01       Impact factor: 3.616

5.  RNA of low molecular weight in KB cells infected with adenovirus type 2.

Authors:  P R Reich; B G Forget; S M Weissman
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

6.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2.

Authors:  H Söderlund; U Pettersson; B Vennström; L Philipson; M B Mathews
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

7.  Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection.

Authors:  R Weinmann; H J Raskas; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

8.  Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.

Authors:  H R Thacore; J S Youngner
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

9.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

10.  The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.

Authors:  S Pilder; M Moore; J Logan; T Shenk
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

View more
  22 in total

1.  Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.

Authors:  A M Ackrill; G R Foster; C D Laxton; D M Flavell; G R Stark; I M Kerr
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

2.  Sensitivity of subgroup F adenoviruses to interferon.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Authors:  Miles C Smith; Adam M Bayless; Erica T Goddard; David J Davido
Journal:  Antiviral Res       Date:  2011-06-22       Impact factor: 5.970

4.  The repression domain of the E1B 55-kilodalton protein participates in countering interferon-induced inhibition of adenovirus replication.

Authors:  Jasdave S Chahal; Courtney Gallagher; Caroline J DeHart; S J Flint
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein.

Authors:  G T Leonard; G C Sen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products.

Authors:  N Reich; R Pine; D Levy; J E Darnell
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

Review 7.  Tumor-suppressor genes: news about the interferon connection.

Authors:  P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  The challenge for gene therapy: innate immune response to adenoviruses.

Authors:  Bart Thaci; Ilya V Ulasov; Derek A Wainwright; Maciej S Lesniak
Journal:  Oncotarget       Date:  2011-03

10.  Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation.

Authors:  D V Kalvakolanu; S K Bandyopadhyay; M L Harter; G C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.